Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders
- 1 April 2002
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 133 (4) , 537-543
- https://doi.org/10.1016/s0002-9394(02)01323-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyPublished by Elsevier ,2002
- New surgical approach for removing massive foveal hard exudates in diabetic macular edema1Published by Elsevier ,1999
- The 14-year incidence of visual loss in a diabetic population,Ophthalmology, 1998
- Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle CellsHypertension, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.Journal of Clinical Investigation, 1993
- Serum Angiotensin Converting Enzyme in Diabetic PatientsThe Lancet Healthy Longevity, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects.Japanese Circulation Journal, 1979